LEGN
Legend BiotechFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
LEGN vs peer average
21/100
LEGN vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · C 2 · D 4 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Gilead is a loose but relevant benchmark through Kite and commercial cell therapy infrastructure; it is far more diversified, so it is better for framing manufacturing and oncology execution standards than for direct valuation comparison.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LEGN
Legend Biotech
GILD
Gilead Sciences
Grade
F
C
Momentum
7
26
Value
41
65
Sentiment
62
51
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs GILD
LEGN / GILD
Grade Position
Below peers
LEGN vs. peer average (F vs. C)
21/100
Momentum
7
GILDValue
41
GILDSentiment
62
LEGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LEGN
GILD is the first peer returned for this comparison set.